Psychiatric and Mood Disorders
Clinical research includes depression with interest in psilocybin therapy, psychedelic-assisted treatment, and the role of support and music in shaping acute and long-term outcomes.
- Depression
- Psilocybin therapy
- Psychedelic-assisted treatment
- Supportive care
- Music intervention
Work in this area centers on therapeutic approaches for mood symptoms and the clinical context surrounding psychedelic treatment.
Obesity and Metabolic Health
Research activity covers obesity, especially childhood-onset obesity persisting into young adulthood, with attention to GLP-1 receptor agonist treatment and obesity-related clinical pathways.
- Obesity
- Childhood-onset obesity
- Young adults
- GLP-1 receptor agonist
- Metabolic regulation
The sponsor’s interest extends to distinguishing lifestyle-responsive and lifestyle-resistant obesity and related biological mechanisms.
Substance Exposure and Safety
Trials include nitrous oxide exposure in the context of recreational use and driving ability, with assessment of blood concentrations and related safety concerns.
- Nitrous oxide
- Recreational substance use
- Driving impairment
- Blood concentrations
- Acute exposure
This area reflects interest in how short-term substance intake relates to physiological elimination and functional performance.
Healthy Volunteers and Human Physiology
Some research activity involves healthy volunteers to study pharmacokinetics, elimination rates, and other human response measures relevant to clinical and behavioral research.
- Healthy volunteers
- Pharmacokinetics
- Elimination rates
- Human response
These studies support investigation of biological handling of substances and measurable effects in controlled human settings.
